General Information of Drug Transporter (DT)
DT ID DTD0425 Transporter Info
Gene Name SLC5A5
Transporter Name Sodium/iodide cotransporter
Gene ID
6528
UniProt ID
Q92911
Post-Translational Modification of This DT
Overview of SLC5A5 Modification Sites with Functional and Structural Information
Sequence
PTM type
X-N-glycosylation X-Phosphorylation X: Amino Acid

N-glycosylation

  Asparagine

          5 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC5A5 [1]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

225

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SLC5A5 Asparagine 225 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC5A5 [2]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

489

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SLC5A5 Asparagine 489 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC5A5 [2]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

502

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SLC5A5 Asparagine 502 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence SLC5A5 [1]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

586

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SLC5A5 Asparagine 586 has the potential to affect its expression or activity.

  PTM Phenomenon 5

Have the potential to influence SLC5A5 [1]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

598

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SLC5A5 Asparagine 598 has the potential to affect its expression or activity.

Phosphorylation

  Serine

          3 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC5A5 [3] , [4]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

43

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC5A5 Serine 43 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC5A5 [5]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

227

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC5A5 Serine 227 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC5A5 [6]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

377

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC5A5 Serine 377 has the potential to affect its expression or activity.

  Threonine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC5A5 [7]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

627

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC5A5 Threonine 627 has the potential to affect its expression or activity.
References
1 Molecular analysis of the sodium/iodide symporter: impact on thyroid and extrathyroid pathophysiology. Physiol Rev. 2000 Jul;80(3):1083-105.
2 dbPTM in 2022: an updated database for exploring regulatory networks and functional associations of protein post-translational modifications. Nucleic Acids Res. 2022 Jan 7;50(D1):D471-D479. (ID: SC5A5_HUMAN)
3 Systematic functional prioritization of protein posttranslational modifications. Cell. 2012 Jul 20;150(2):413-25.
4 Identification of in vivo phosphorylation sites and their functional significance in the sodium iodide symporter. J Biol Chem. 2007 Dec 21;282(51):36820-8.
5 Quantification of pancreatic cancer proteome and phosphorylome: indicates molecular events likely contributing to cancer and activity of drug targets. PLoS One. 2014 Mar 26;9(3):e90948.
6 Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics. 2014 Jul;13(7):1690-704.
7 Integrated analysis of global proteome, phosphoproteome, and glycoproteome enables complementary interpretation of disease-related protein networks. Sci Rep. 2015 Dec 11;5:18189.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.